Tuesday, November 17, 2026
RSS

Markets-and-Money

Aytu BioPharma Buyout Sets $2.70 Per-Share Target for Investors

Rosemont’s agreement to acquire Aytu BioPharma at $2.70 per share gives small-cap healthcare investors a clear merger-arbitrage reference point.

November 17, 2026
Markets-and-Money

DOJ Review Puts DoorDash’s Instacart Deal Under the Antitrust Microscope

A DOJ review adds regulatory uncertainty to DoorDash’s proposed Instacart acquisition, putting timing and merger-arbitra…

Nov 17
Markets-and-Money

Carlisle’s PermaTherm Deal Expands Its Building-Products Footprint

Carlisle’s agreement to acquire PermaTherm adds insulated metal panels and related products to its building-envelope pla…

Nov 17
Tech

Anthropic Sets $70-$78 IPO Range for Nasdaq Debut Under ANT

Anthropic’s proposed $70-$78 IPO range will put AI investor appetite and high-growth valuations to a live test when ANT …

Nov 16
Free Newsletter

Informed positions start with informed mornings.

Market-moving analysis and institutional-grade research, complimentary and delivered daily.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories